CN109316494A - Purposes of the badger seed oil in preparation treatment ephritis medicine or health food - Google Patents
Purposes of the badger seed oil in preparation treatment ephritis medicine or health food Download PDFInfo
- Publication number
- CN109316494A CN109316494A CN201710639167.6A CN201710639167A CN109316494A CN 109316494 A CN109316494 A CN 109316494A CN 201710639167 A CN201710639167 A CN 201710639167A CN 109316494 A CN109316494 A CN 109316494A
- Authority
- CN
- China
- Prior art keywords
- seed oil
- medicine
- badger
- purposes
- ephritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282346 Meles meles Species 0.000 title claims abstract description 26
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 235000013402 health food Nutrition 0.000 title claims abstract description 10
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 4
- 230000001186 cumulative effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 201000008383 nephritis Diseases 0.000 abstract description 2
- 239000002547 new drug Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 238000009509 drug development Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 201000001474 proteinuria Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 241001504654 Mustela nivalis Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to food and medicine fields, i.e. purposes of the badger seed oil in preparation treatment ephritis medicine or health food.By cumulative statistics patient totally 42, badger seed oil is taken, continuous to treat 2-3 months, treatment results: complete incidence graph 23 (54.76%), alleviating 13 (30.95%) substantially, it is effective 5 (11.9%), it is invalid 1 (2.39%).Total effective rate 97.61%.Disclosing badger seed oil has significant therapeutic effect to nephritis, to provide certain experimental basis for ephritis new drug development and health care product exploitation.
Description
Technical field
The present invention relates to food and medicine fields, i.e. purposes of the badger seed oil in preparation treatment ephritis medicine or health food.
Background technique
In the prior art, badger (Meles meles) it is also known as badger, badger, day dog, Carnivora belongs to larger kind of weasel class.Badger
Back from the beginning to the end with long and thick needle hair, color be it is dark brown mix with white, present taupe.The solid fertilizer of the bodily form
Greatly, four limbs are short, the short circle of auricular concha, the small nose of eye, neck tubbiness.Badger seed oil is boiled with the subcutaneous fat processing of badger, is me
It is used to treat one of important medicinal material of scald between its people, has effects that tonifying middle-Jiao and Qi, moisturizing myogenic, removing toxicity for detumescence.External application can
It is for oral administration to can treat intestines to treat burn and scald, scleroma, Changes of Radiation Damaged Skin, virus infected herpes, alopecia, inside and outside hemorrhoid gall
Obstruction, Sha Jie, gastric ulcer, uterine prolapse and hemiplegia.
The physiological function of kidney is mainly excretion metabolism product and adjusts water, electrolyte and acid-base balance, secretes a variety of work
Property substance, maintain body homeostasis, to guarantee the normal physiological function of body.Ephritis (glomerulonephritis) is situated between by immune
Lead, inflammatory mediator (such as complement, cell factor, active oxygen) participates in, finally results in kidney and inherently organizes that inflammatory change occurs,
One group of kidney trouble for causing different degrees of renal hypofunction, can be caused by Different types of etiopathogenises.Also have in chronic process it is nonimmune,
Noninflammatory mechanism participates in.Common sympton: out of strength, flank pain receives difference, gross hematuria, oedema, hypertension, renal dysfunction, urine
Amount is reduced, congestive heart failure etc..Treatment ephritis medicine is many kinds of, and curative effect is different.
Summary of the invention
The purpose of the present invention is a kind of badger seed oil medicine, health food new application, i.e. badger are provided for above situation
Purposes of the oil in preparation treatment ephritis medicine or health food.
The technical solution of the invention is as follows: purposes of the badger seed oil in preparation treatment ephritis medicine or health food.Badger
Seed oil is boiled with the subcutaneous fat processing of badger.
Using badger seed oil as main active, preparation treatment ephritis medicine can be single dose or compound formulation.It can be added
One or more active constituents with collaboration or booster action are made, and can add common pharmaceutical carrier, such as figuration in pharmacy
Agent or auxiliary material, drug, food formulation are unlimited, can be tablet, capsule (soft capsule), granule, powder, pill, liquid
Preparation or other conventional formulations.
Using badger seed oil as main active, can be added in health food.Dosage form is unlimited.
Usage and dosage: twice daily, each 5-10ml, 20 days take effect, and medication 2-3 months.
The invention has the advantages that badger seed oil is taken by cumulative statistics patient totally 42, and it is continuous to treat 2-3 months, it controls
It treats result: complete incidence graph 23 (54.76%), alleviating 13 (30.95%) substantially, it is effective 5 (11.9%), invalid 1
(2.39%).Total effective rate 97.61%.Disclosing badger seed oil has significant therapeutic effect to nephritis, to be ephritis new drug
Research and development provide certain experimental basis with health care product exploitation.
Embodiments of the present invention are described in further detail below in conjunction with embodiment.
Specific embodiment
Embodiment
Purposes of the badger seed oil in preparation treatment ephritis medicine or health food.Badger seed oil is processed with the subcutaneous fat of badger
It boils.
Experimental example
Clinical data
1, cumulative statistics patient 42, male 24, female 18, for patient age between 26-58 years old, it is 1 year that patient's course of disease is most short,
Longest 8 years.
2, usage and dosage: each 10ml, 2 times a day, medication 2-3 months.
3, efficacy assessment standard:
Complete incidence graph: the symptoms such as oedema, Renal hypertension, sign completely disappear, and Urine proteins continue feminine gender, quantitative <
0.2g/24h, urine erythrocyte continue 2/HP of <, normal renal function.
Substantially alleviate: symptom, sign disappear substantially, reduction 50% before quantity of proteinuria is relatively treated, and urine erythrocyte < 2/
HP, normal renal function.
Effective: symptom, sign are clearly better, and 25% are reduced before quantity of proteinuria ratio treatment, serum creatinine (Scr) is normal or compares
Rise < 50% before treatment.
It is invalid: effective standard is not achieved.
4, treatment results count: complete incidence graph 23 (54.76%), substantially 13 (30.95%) of alleviation, and effective 5
(11.9%), invalid 1 (2.39%).Total effective rate 97.61%.
Claims (2)
1. purposes of the badger seed oil in preparation treatment ephritis medicine or health food.
2. purposes as described in claim 1, it is characterized in that badger seed oil is boiled with the subcutaneous fat processing of badger.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710639167.6A CN109316494A (en) | 2017-07-31 | 2017-07-31 | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710639167.6A CN109316494A (en) | 2017-07-31 | 2017-07-31 | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109316494A true CN109316494A (en) | 2019-02-12 |
Family
ID=65244928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710639167.6A Pending CN109316494A (en) | 2017-07-31 | 2017-07-31 | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109316494A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393949A (en) * | 2013-08-04 | 2013-11-20 | 杜晓娅 | Traditional Chinese medicinal composition for treating chronic glomerulonephritis |
| CN104547471A (en) * | 2014-12-09 | 2015-04-29 | 李国华 | Medicine for treating nephritis |
| CN105055708A (en) * | 2015-07-28 | 2015-11-18 | 吴斌 | Medicine for treating nephritis |
| CN106138682A (en) * | 2015-04-13 | 2016-11-23 | 张金桃 | A kind of Chinese medicine oral liquid treating nephritis |
| CN106138239A (en) * | 2016-07-30 | 2016-11-23 | 庄炎 | A kind of Chinese medicine preparation treating chronic glomerulonephritis |
| CN106552169A (en) * | 2015-09-28 | 2017-04-05 | 周丽球 | A kind of Chinese medicine oral liquid for treating nephritis |
-
2017
- 2017-07-31 CN CN201710639167.6A patent/CN109316494A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393949A (en) * | 2013-08-04 | 2013-11-20 | 杜晓娅 | Traditional Chinese medicinal composition for treating chronic glomerulonephritis |
| CN104547471A (en) * | 2014-12-09 | 2015-04-29 | 李国华 | Medicine for treating nephritis |
| CN106138682A (en) * | 2015-04-13 | 2016-11-23 | 张金桃 | A kind of Chinese medicine oral liquid treating nephritis |
| CN105055708A (en) * | 2015-07-28 | 2015-11-18 | 吴斌 | Medicine for treating nephritis |
| CN106552169A (en) * | 2015-09-28 | 2017-04-05 | 周丽球 | A kind of Chinese medicine oral liquid for treating nephritis |
| CN106138239A (en) * | 2016-07-30 | 2016-11-23 | 庄炎 | A kind of Chinese medicine preparation treating chronic glomerulonephritis |
Non-Patent Citations (2)
| Title |
|---|
| DOROTA MARTYSIAK-ŻUROWSKA ET AL.: "Unusual odd-chain and trans-octadecenoic fatty acids in tissues of feral European beaver (Castor fiber), Eurasian badger (Meles meles) and raccoon dog (Nyctereutes procyonoides)", 《COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY》 * |
| 冰冷的暖水瓶: "獾子油治疗慢性肾衰怎么样", 《HTTPS://ZHIDAO.BAIDU.COM/QUESTION/126552568.HTML》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988772B (en) | TCM (Traditional Chinese medicine) composition for treating infantile acute infantile convulsions and preparation method thereof | |
| CN101632750B (en) | Chinese medicinal composition for replenishing essence, filling marrow, boosting kidney and strengthening yang and preparation method thereof | |
| WO2023109747A1 (en) | Use of 2,4-dihydroxybenzoic acid in drug for treating iron overload diseases | |
| CN102872241A (en) | Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof | |
| CN102579700B (en) | Medicinal liquor for treating arthritis | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102091141A (en) | Medicament for treating gout and preparation method thereof | |
| CN103356697A (en) | Stem cell preparation and oral fluid prepared therefrom | |
| CN109316494A (en) | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN101623339A (en) | Traditional Chinese medicine for treating white hair | |
| CN104013867A (en) | Traditional Chinese medicine for treating eczema | |
| CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
| CN103446283A (en) | Pharmaceutical composition for preventing and treating chemotherapy stomatitis | |
| CN105435048A (en) | Traditional Chinese medicine for treatment of thyroid tumor | |
| CN105343419A (en) | Traditional Chinese medicinal pill for invigorating yang and tonifying kidney, and preparation method thereof | |
| CN104800784A (en) | Medicine for treating heart cerebrovascular diseases | |
| CN109316493A (en) | Purposes of the badger seed oil in preparation treatment cholecystitis drug or health food | |
| CN109316492A (en) | Purposes of the badger seed oil in preparation treatment pancreatitis drug or health food | |
| CN109758559A (en) | A kind of Chinese medicine composition and its preparation method and application for treating chronic fatigue syndrome | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN103719661A (en) | Oral liquid health product with function of replenishing blood | |
| Patil et al. | Review on Gomutra (Cow Urine) | |
| CN106822271A (en) | It is a kind of to treat pharmaceutical composition of rheumatic Bi syndrome and its production and use | |
| CN102240330B (en) | Medicinal composition for strengthening bones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190212 |